Search research articles
Contact Us
Filters
Showing results (431-440 of 709) with videos related to
Page
of 71
Sort By:
Zhonghua Yi Xue Za Zhi
|
May 15, 2008
[Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro]
Xiao-dan Wang, Lin Qiu, Run-zhang Lu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
March 4, 2010
[Norcantharidin induces apoptosis in SMMC-7721 cells via the c-Jun-NH2-terminal kinase signaling pathways]
Xian-qian Li, Shi-he Shao, Xiao-hong Han, et al.
World Journal of Gastroenterology
|
November 22, 2013
Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: an 8-year retrospective single-center study
Xing-Shun Qi, Ming Bai, Chuang-Ye He, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 1, 2020
Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124
Wei Miao, Yong Yan, Tian-Hao Bao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 17, 2020
Corrigendum to "Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124" [Biomed. Pharmacother. 126 (2020) 109786]
Wei Miao, Yong Yan, Tian-Hao Bao, et al.
Frontiers in Pharmacology
|
August 27, 2024
Osteoporosis treatment: current drugs and future developments
Ya-Jing Chen, Li-Hua Jia, Tao-Hong Han, et al.
Therapeutic Advances in Musculoskeletal Disease
|
January 24, 2022
Based on minimal clinically important difference values, a moderate dose of tanezumab may be a better option for treating hip or knee osteoarthritis: a meta-analysis of randomized controlled trials
Di Zhao, Ming-Hui Luo, Jian-Ke Pan, et al.
Biochemical and Biophysical Research Communications
|
February 14, 2021
METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC
Zhuoyang Fan, Yang Gao, Wei Zhang, et al.
International Journal of Molecular Sciences
|
November 19, 2020
Sustained Exposure of Substance P Causes Tendinopathy
Seo Yoon Oh, Do Kyung Kim, Soo Hong Han, et al.
EFORT Open Reviews
|
July 28, 2022
Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials
Di Zhao, Ling-Feng Zeng, Gui-Hong Liang, et al.
Page
of 71
Search research articles
Search
Showing results (431-440 of 709) with videos related to
Sort By:
Page
of 71
Zhonghua Yi Xue Za Zhi
|
May 15, 2008
[Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro]
Xiao-dan Wang, Lin Qiu, Run-zhang Lu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
March 4, 2010
[Norcantharidin induces apoptosis in SMMC-7721 cells via the c-Jun-NH2-terminal kinase signaling pathways]
Xian-qian Li, Shi-he Shao, Xiao-hong Han, et al.
World Journal of Gastroenterology
|
November 22, 2013
Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: an 8-year retrospective single-center study
Xing-Shun Qi, Ming Bai, Chuang-Ye He, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 1, 2020
Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124
Wei Miao, Yong Yan, Tian-Hao Bao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 17, 2020
Corrigendum to "Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124" [Biomed. Pharmacother. 126 (2020) 109786]
Wei Miao, Yong Yan, Tian-Hao Bao, et al.
Frontiers in Pharmacology
|
August 27, 2024
Osteoporosis treatment: current drugs and future developments
Ya-Jing Chen, Li-Hua Jia, Tao-Hong Han, et al.
Therapeutic Advances in Musculoskeletal Disease
|
January 24, 2022
Based on minimal clinically important difference values, a moderate dose of tanezumab may be a better option for treating hip or knee osteoarthritis: a meta-analysis of randomized controlled trials
Di Zhao, Ming-Hui Luo, Jian-Ke Pan, et al.
Biochemical and Biophysical Research Communications
|
February 14, 2021
METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC
Zhuoyang Fan, Yang Gao, Wei Zhang, et al.
International Journal of Molecular Sciences
|
November 19, 2020
Sustained Exposure of Substance P Causes Tendinopathy
Seo Yoon Oh, Do Kyung Kim, Soo Hong Han, et al.
EFORT Open Reviews
|
July 28, 2022
Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials
Di Zhao, Ling-Feng Zeng, Gui-Hong Liang, et al.
Page
of 71